Struewing et al. reported that four (3.6%) and fifteen (13.6%) of 110 Israeli Jewish male breast cancer patients carried the BRCA1 185delAG and BRCA2 6174delT founder mutation, respectively, but not BRCA1 5382insC [74]. Here, BRCA2 is linked to breast carcinoma.